Cancer Research Collaboration Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 4,086 | 20,100 | −16,014 | -9.6 | — |
| 2013 | 276,259 | 539,799 | −263,540 | -6.2 | 64% |
| 2014 | 616,841 | 602,702 | 14,139 | -5.3 | 65% |
| 2015 | 589,108 | 716,141 | −127,033 | -6.6 | 68% |
| 2016 | 1,046,951 | 969,982 | 76,969 | -3.9 | 52% |
| 2017 | 2,054,196 | 2,004,234 | 49,962 | -1.6 | 47% |
| 2018 | 2,055,057 | 1,994,676 | 60,381 | 7.5 | 27% |
| 2019 | 1,740,972 | 1,741,166 | −194 | 8.6 | 17% |
| 2020 | 66,695 | 36,586 | 30,109 | 420.6 | 0% |
| 2021 | 11,003 | 109,403 | −98,400 | 114.3 | 0% |
| 2022 | 213,380 | 238,786 | −25,406 | 51.1 | 0% |
| 2023 | 151,199 | 302,509 | −151,310 | 36.4 | 0% |
In its most recent public year (2023), this organization spent $151,310 more than it brought in. Its reserves stood at about 36.4 months of spending, up from -9.6 in 2012. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Cancer Research Collaboration Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works